Probiotics: Supplements, Food, Pharmaceutical Industry

Therapeutic, Probiotic, and Unconventional Foods

Volumn , Issue , 2018, Pages 15-25

  Putta, Swathi ^a   Yarla, Nagendra S ^b   Lakkappa, Dhananjaya B ^c   Imandi, Sarat B ^d   Malla, Rama Rao ^b   Chaitanya, Amajala K ^b   Chari, Brahma P V ^b   Saka, Silas ^d   Vechalapu, Rama Rao ^d   Kamal, Mohammad A ^e,f,g   Tarasov, Vadim V ^h   Chubarev, Vladimir N ^h   Siva Kumar, Korada ⁱ   Aliev, Gjumrakch ^j,k,l  

^a ANDHRA UNIVERSITY   (India)

^b GITAM UNIVERSITY   (India)

^c JAIN UNIVERSITY   (India)

^d KRISHNA UNIVERSITY   (India)

^e KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^f Enzymoics   (Australia)

^g Global Community Educational Foundation   (Australia)

^h I M SECHENOV FIRST MOSCOW STATE MEDICAL UNIVERSITY   (Russian Federation)

ⁱ NATIONAL INSTITUTE OF FOOD TECHNOLOGY ENTREPRENEURSHIP AND MANAGEMENT   (India)

^j GALLY International Biomedical Research Consulting LLC   (United States)

^k University of Atlanta   (United States)

^l RUSSIAN ACADEMY OF SCIENCES   (Russian Federation)

more..

Author keywords

Functional foods; Health benefits; Probiotics

Indexed keywords

EID: 85075050960     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-814625-5.00002-9     Document Type: Chapter

References (92)

1. An H.M., Park S.Y., Lee K., Kim J.R., Cha M.K., Lee S.W. Antiobesity and lipid-lowering effects of Bifidobacterium spp. in high fat diet-induced obese rats. Lipids Health Dis. 2011, 10:116.
2. Andersson U., Bränning C., Ahrné S., Molin G., Alenfall J., Onning G., Nyman M., Holm C. Probiotics lower plasma glucose in the high-fat fed C57BL/6J mouse. Benefic. Microbes 2010, 1:189-196.
3. Andreasen A.S., Larsen N., Pedersen S.T. Effects of Lactobacillus acidophilus NCFM on insulin sensitivity and the systemic inflammatory response in human subjects. Br. J. Nutr. 2010, 104(12):1831-1838.
4. Apás A.L., Dupraz J., Ross R., González S.N., Arena M.E. Probiotic administration effect on fecal mutagenicity and microflora in the goat's gut. J. Biosci. Bioeng. 2010, 110:537-540.
5. Aronsson L., Huang Y., Parini P. Decreased fat storage by Lactobacillus paracasei is associated with increased levels of angiopoietin-like 4 protein (ANGPTL4). PLoS One 2010, 5(9).
6. Asemi Z., Zare Z., Shakeri H., Sabihi S., Esmaillzadeh A. Effect of multispecies probiotic supplements on metabolic profiles, hs-CRP, and oxidative stress in patients with type 2 diabetes. Ann. Nutr. Metab. 2013, 63(1):1-9.
7. Asemi Z., Khorrami-Rad A., Alizadeh S.A., Shakeri H., Esmaillzadeh A. Effects of synbiotic food consumption on metabolic status of diabetic patients: a double-blind randomized cross-over controlled clinical trial. Clin. Nutr. 2014, 33(2):198-203.
8. Baldwin C., Millette M., Oth D., Ruiz M.T., Luquet F.M. Probiotic Lactobacillus acidophilus and L. casei mix sensitize colorectal tumoral cells to 5-fluorouracil-induced apoptosis. Nutr. Cancer 2010, 62:371-378.
9. Bertkova I., Hijova E., Chmelarova A., Mojzisova G., Petrasova D., Strojny L., Bomba A., Zitnan R. The effect of probiotics microorganisms and bioactive compounds on chemically induced carcinogenesis in rats. Neoplasma 2010, 57:422-428.
10. Calafiore A., Gionchetti P., Calabrese C., Tambasco R., Fornarini G.S., Liguori G., Riso D., Campieri M., Rizzello F. Probiotics, prebiotics and antibiotics in the treatment of inflammatory bowel disease. J. Gastroenterol. Hepatol. Res. 2012, 1(6):97-106.
11. Castagliuolo I., Riegler M.F., Valenick L., LaMont J.T., Pothoulakis C. Saccharomyces boulardii protease inhibits the effects of Clostridium difficile toxins A and B in human colonic mucosa. Infect. Immun. 1999, 67:302-307.
12. Chen J., Wang R., Li X.F., Wang R.L. Bifidobacterium adolescentis supplementation ameliorates visceral fat accumulation and insulin sensitivity in an experimental model of the metabolic syndrome. Br. J. Nutr. 2012, (10):1429-1434.
13. Cummings J.H., Macfarlane G.T. Role of intestinal bacteria in nutrient metabolism. J. Parenter. Enter. Nutr. 1997, 21:357-365.
14. De Preter V., Hamer H.M., Windey K., Verbeke K. The impact of pre- and/or probiotics on human colonic metabolism: does it affect human health?. Mol. Nutr. Food Res. 2011, 55:46-57.
15. Dhiman R.K., Rana B., Agrawal S. Probiotic VSL#3 reduces liver disease severity and hospitalization in patients with cirrhosis: a randomized, controlled trial. Gastroenterology 2014, 147(6):1327-1337.
16. Ejtahed H.S., Mohtadi-Nia J., Homayouni-Rad A., Niafar M., Asghari-Jafarabadi M., Mofid V., Akbarian-Moghari A. Effect of probiotic yogurt containing Lactobacillus acidophilus and Bifidobacterium lactis on lipid profile in individuals with type 2 diabetes mellitus. J. Dairy Sci. 2011, 94:3288-3294.
17. Ejtahed H.S., Mohtadi-Nia J., Homayouni-Rad A., Niafar M., Asghari-Jafarabadi M., Mofid V. Probiotic yogurt improves antioxidant status in type 2 diabetic patients. Nutrition 2012, 28:539-543.
18. Endo H., Niioka M., Kobayashi N., Tanaka M., Watanabe T. Butyrate-producing probiotics reduce nonalcoholic fatty liver disease progression in rats: new insight into the probiotics for the gut-liver axis. PLoS One 2013, 8(5).
19. Everard A., Matamoros S., Geurts L., Delzenne N.M., Cani P.D. Saccharomyces boulardii administration changes gut microbiota and reduces hepatic steatosis, low-grade inflammation, and fat mass in obese and type 2 diabetic db/db mice. MBio 2014, 5(3):e01011-e01014.
20. Fang S.B., Lee H.C., Hu J.J. Dose-dependent effect of Lactobacillus rhamnosus on quantitative reduction of fecal rotavirus shedding in children. J. Trop. Pediatr. 2009, 55:297-301.
21. FAO/WHO Guidelines for the evaluation of probiotics in Food. Report of a joint Food and Agriculture Organisation of the United Nations/World Health Organisation Working Group on Drafting guidelines for the evaluation of probiotics in food 2002, London, Ontario, Canada.
22. Furet J.P., Kong L.C., Tap J., Poitou C., Basdevant A., Bouillot J.L., Mariat D. Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers. Diabetes 2010, 59:3049-3057.
23. Galdeano C.M., Moreno de LeBlanc A., Vinderola G., Bonet M.E., Perdigón G. Proposed model: mechanisms of immunomodulation induced by probiotic bacteria. Clin. Vaccine Immunol. 2007, 14:485-492.
24. Gianotti L., Morelli L., Galbiati F., Rocchetti S., Coppola S., Beneduce A., Gilardini C., Zonenschain D., Nespoli A., Braga M. A randomized double-blind trial on perioperative administration of probiotics in colorectal cancer patients. World J. Gastroenterol. 2010, 16:167-175.
25. Giovannini M., Agostoni C., Riva E., Salvini F., Ruscitto A., Zuccotti G.V. A randomized prospective double blind controlled trial on effects of longterm consumption of fermented milk containing Lactobacillus casei in pre-school children with allergic asthma and/or rhinitis. Pediatr. Res. 2007, 62:215-220.
26. Goffau M., Luopajärvi K., Knip M., Ilonen J., Ruohtula T., Härkönen T., Orivuori L., Hakala S., Welling G.W., Harmsen H.J., Vaarala O. Fecal microbiota composition differs between children with beta-cell autoimmunity and those without. Diabetes 2013, 62:1238-1244.
27. Helin T., Haahtela S., Haahtela T. No effect of oral treatment with an intestinal bacterial strain, Lactobacillus rhamnosus (ATCC 53103), on birch-pollen allergy: a placebo-controlled double-blind study. Allergy 2002, 57:243-246.
28. Hol J., Van Leer E.H., Elink-Schuurman B.E., Ruiter L.F., Samsom J.N., Hop W. The acquisition of tolerance toward cow's milk through probiotic supplementation: a randomized, controlled trial. J. Allergy Clin. Immunol. 2008, 121:1448-1454.
29. Hong M., Kim S.W., Han S.H., Kim D.J., Suk K.T., Kim Y.S., Kim M.J., Kim M.Y., Baik S.K., Ham Y.L. Probiotics (Lactobacillus rhamnosus R0011 and acidophilus R0052) reduce the expression of toll-like receptor 4 in mice with alcoholic liver disease. PLoS One 2015, 10(2).
30. Hsieh F.C., Lee C.L., Chai C.Y. Oral administration of Lactobacillus reuteri GMNL-263 improves insulin resistance and ameliorates hepatic steatosis in high fructose-fed rats. Nutr. Metab. 2013, 10:35.
31. Kalliomaki M., Salminen S., Arvilommi H., Kero P., Koskinen P., Isolauri E. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 2001, 357(9262):1076-1079.
32. Kato I., Yokokura T., Mutai M. Correlation between increase in Ia-bearing macrophages and induction of T cell-dependent antitumor activity by Lactobacillus casei in mice. Cancer Immunol. Immunother. 1988, 26:215-221.
33. Kedar S., Shashikant M.C., Priya T., Sultana N., Nallan C.S.K. Probiotics-do they have a role in medicine and dentistry. J. Assoc. Physicians India 2010, 58:488-492.
34. Kuczynski J., Lauber C.L., Walters W.A. Experimental and analytical tools for studying the human microbiome. Nat. Rev. Genet. 2011, 13(1):47-58.
35. Kumar A. Probiotics: Nature's medicine. Int. J. Nutr. Pharmacol. Neurol. Dis 2013, 3:219-228.
36. Kumar M., Verma V., Nagpal R., Kumar A., Gautam S.K., Behare P.V., Grover C.R., Aggarwal P.K. Effect of probiotic fermented milk and chlorophyllin on gene expressions and genotoxicity during AFB1-induced hepatocellular carcinoma. Gene 2011, 490:54-59.
37. Kumar M., Nagpal R., Verma V., Kumar A., Kaur N., Hemalatha R., Gautam S.K., Singh B. Probiotic metabolites as epigenetic targets in the prevention of colon cancer. Nutr. Rev. 2013, 71:23-34.
38. Lanning D.K., Rhee K.J., Knight K.L. Intestinal bacteria and development of the B-lymphocyte repertoire. Trends Immunol. 2005, 26:419-425.
39. Lawrence M., Xiaoming L., Fengwei T., Jianxin Z., Hao Z., Wei C. Screening for lactic acid bacteria based on antihyperglycaemic and probiotic potential and application in synbiotic set yoghurt. J. Funct. Foods 2015, 16:125-136.
40. Lee D.K., Jang S., Baek E.H., Kim M.J., Lee K.S., Shin H.S., Chung M.J., Kim J.E., Lee K.O., Ha N.J. Lactic acid bacteria affect serum cholesterol levels, harmful fecal enzyme activity, and fecal water content. Lipids Health Dis. 2009, 8:21.
41. Lee D.K., Kang J.Y., Shin H.S., Park I.H., Ha N.J. Antiviral activity of Bifidobacterium adolescentis SPM0212 against Hepatitis B virus. Arch. Pharm. Res. 2013, 36(12):1525-1532.
42. Lin W.H., Hwang C.F., Chen L.W., Tsen H.Y. Viable counts, characteristic evaluation for commercial lactic acid bacteria products. Food Microbiol. 2006, 23(1):74-81.
43. Liu H.Y., Roos Y., Jonsson H., Ahl D., Dicksved J., Lindberg J.E., Lundh T. Effects of Lactobacillus johnsonii and Lactobacillus reuteri on gut barrier function and heat shock proteins in intestinal porcine epithelial cells. Phys. Rep. 2015, 3(4):e12355.
44. Loguercio C., Federico A., Tuccillo C. Beneficial effects of a probiotic VSL#3 on parameters of liver dysfunction in chronic liver diseases. J. Clin. Gastroenterol. 2005, 39(6):540-543.
45. Lu Z.X., Walker K.Z., Muir J.G., O'Dea K. Arabinoxylan fibre improves metabolic control in people with type II diabetes. Eur. J. Clin. Nutr. 2004, 58(4):621-628.
46. Lu Y.C., Yin L.T., Chang W.T., Huang J.S. Effect of Lactobacillus reuteri GMNL-263 treatment on renal fibrosis in diabetic rats. J. Biosci. Bioeng. 2010, 110:709-715.
47. Majamaa H., Isolauri E. Probiotics: a novel approach in the management of food allergy. J. Allergy Clin. Immunol. 1997, 99:179-185.
48. Marotta F., Barreto R., Wu C.C. Experimental acute alcohol pancreatitis-related liver damage and endotoxemia: synbiotics but not metronidazole have a protective effect. Chin. J. Dig. Dis. 2005, 6(4):193-197.
49. Marteau P., Vrese M., Cellier C.J., Schrezenmeir J. Protection from gastrointestinal diseases with the use of probiotics. Am. J. Clin. Nutr. 2001, 73:430-436.
50. Matsuzaki T., Yamazaki R., Hashimoto S., Yokokura T. Antidiabetic effects of an oral administration of Lactobacillus casei in a non-insulin-dependent diabetes mellitus (NIDDM) model using KK-Ay mice. Endocr. J. 1997, 44:357-365.
51. Mazloom Z., Yousefinejad A., Dabbaghmanesh M.H. Effect of probiotics on lipid profile, glycemic control, insulin action, oxidative stress, and inflammatory markers in patients with type 2 diabetes: a clinical trial. Iran. J. Med. Sci. 2013, 38:38-43.
52. Mohan J.C. Preliminary observations on effect of L. sporogenes on serum lipid levels in hypercholesterolemic patients. Indian J. Med. Res. 1990, 92:431-432.
53. Murguia-Peniche T., Mihatsch W.A., Zegarra J., Supapannachart S., Ding Z.Y., Neu J. Intestinal mucosal defense system, Part 2. Probiotics and prebiotics. J. Pediatr. 2013, 162(3):64-71.
54. Murri M., Leiva I., Gomez-Zumaquero J.M., Tinahones F.J., Cardona F., Soriguer F., Queipo-Ortuño M.I. Gut microbiota in children with type 1 diabetes differs from that in healthy children: a case-control study. BMC Med. 2013, 11(46).
55. Nardone G., Compare D., Liguori E., Di Mauro V., Rocco A., Barone M., Napoli A., Lapi D., Iovene M.R., Colantuoni A. Protective effects of Lactobacillus paracasei F19 in a rat model of oxidative and metabolic hepatic injury. Am. J. Physiol. Gastrointest. Liver Physiol. 2010, 299:G669-G676.
56. Narwal A., Shashi B. Probiotics in dentistry-a review. J. Nutr. Food Sci. 2011, 1:114.
57. Nualkaekul S., Lenton D., Cook M.T., Khutoryanskiy V.V., Charalampopoulos D. Chitosan coated alginate beads for the survival of microencapsulated Lactobacillus plantarum in pomegranate juice. Carbohydr. Polym. 2012, 90:1281-1287.
58. Oberhelman R.A., Gilman R.H., Sheen P., Taylor D.N., Black R.E., Cabrera L., Lescano A.G., Meza R., Madico G. A placebo-controlled trial of Lactobacillus GG to prevent diarrhea in undernourished Peruvian children. J. Pediatr. 1999, 134:15-20.
59. Okawa T., Niibe H., Arai T. Effect of LC 9018 combined with radiation therapy on carcinoma of the uterine cervix. Cancer 1993, 72:1949-1954.
60. Park K.Y., Kim B., Hyun C.K. Lactobacillus rhamnosus GG improves glucose tolerance through alleviating ER stress and suppressing macrophage activation in db/db mice. J. Clin. Biochem. Nutr. 2015, 56:240-246.
61. Parvez S., Lee H.C., Kim D.S., Kim H.Y. Bile salt hydrolase and chlolesterol removal effect by Bifidobacterium bifidum NRRL 1976. World J. Microbiol. Biotechnol 2005.
62. Patil M.B., Reddy N. Bacteriotherapy and probiotics in dentistry. KSDJ 2006, 2:98-102.
63. Qin J., Li R., Raes J., Arumugam M., Burgdorf K.S., Manichanh C. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010, 464:59-65.
64. Rafter J., Bennett M., Caderni G., Clune Y., Hughes R., Karlsson P.C. Dietary synbiotics reduce cancer risk factors in polypectomized and colon cancer patients. Am. J. Clin. Nutr. 2007, 85:488-496.
65. Rastogi P., Saini H., Dixit J., Singhal R. Probiotics and oral health. Natl. J. Maxillofac. Surg. 2011, 2:6-9.
66. Resta S.C. Effects of probiotics and commensals on intestinal epithelial physiology: implications for nutrient handling. J. Physiol. 2009, 587:4169-4174.
67. SCAN Report of the Scientific Committee on Animal Nutrition on the Safety of Use of Bacillus Species in Animal Nutrition 2000, European Commission Health & Consumer Protection Directorate-General. http://europa.eu.int/comm/food/fs/sc/scan/out41.pdf.
68. Sekine K., Watanabe Sekine E., Ohta J. Induction and activation of tumoricidal cells in vitro and (in vivo by the bacterial cell wall of B infants). Bifidobacteria Microflora 1994, 13:54-77.
69. Soccol C.R., Souza Vandenberghe L.P., Spier M.R., Medeiros A.B.P., Yamaguishi C.T., Lindner D.D., Pandey J.A., Thomaz-Soccol V. The potential of probiotics: a review. Food Technol. Biotechnol. 2010, 48(4):413-434.
70. Stetinova V., Smetanova L., Kvetina J., Svoboda Z., Zidek Z., Tlaskalova-Hogenova H. Caco-2 cell monolayer integrity and effect of pro-biotic Escherichia coli Nissle 1917 components. Neuro Endocrinol. Lett. 2010, 31(2):51-56.
71. Surawicz C.M., Elmer G.W., Speelman P., MacFarland L.V., Chinn J., Belle G. Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: a prospective study. Gastroenterology 1989, 96:981-988.
72. Szajewska H., Skorka A., Ruszczynski M. Meta-analysis: Lactobacillus GG for treating acute diarrhoea in children. Aliment. Pharmacol. Ther. 2007, 25:871-881.
73. Tiwari G., Tiwari R., Pandey S., Pandey P. Promising future of probiotics for human health: current scenario. Chron. Young Sci. 2012, 3:17-28.
74. Turnbaugh P.J., Hamady M., Yatsunenko T., Cantarel B.L., Duncan A., Ley R.E. A core gut microbiome in obese and lean twins. Nature 2009, 457:480-484.
75. Vajro P., Mandato C., Licenziati M.R. Effects of Lactobacillus rhamnosus strain GG in pediatric obesity-related liver disease. J. Pediatr. Gastroenterol. Nutr. 2011, 52(6):740-743.
76. Vanderhoof J.A. Probiotics and intestinal inflammatory disorders in infants and children. J. Pediatr. Gastroenterol. Nutr. 2000, 30:34-38.
77. Villarini M., Caldini G., Moretti M., Trotta F., Pasquini R., Cenci G. Modulatory activity of a Lactobacillus casei strain on 1,2-dimethylhydrazine-induced genotoxicity in rats. Environ. Mol. Mutagen. 2008, 49:192-199.
78. Wang Y.I., Kirpich Y., Liu Lactobacillus rhamnosus GG treatment potentiates intestinal hypoxia-inducible factor, promotes intestinal integrity and ameliorates alcohol-induced liver injury. Am. J. Pathol. 2011, 179(6):2866-2875.
79. Wang S.Y., Chen K.N., Lo Y.M., Chiang M.L., Chen H.C., Liu J.R., Chen M.J. Investigation of microorganisms involved in biosynthesis of the kefir grain. Food Microbiol. 2012, 32(2):274-285.
80. Wang Y.Y., Liu I., Kirpich Lactobacillus rhamnosus GG reduces hepatic TNFalpha production and inflammation in chronic alcohol-induced liver injury. J. Nutr. Biochem. 2013, 24(9):1609-1615.
81. Weston S., Halbert A., Richmond P., Prescott S.L. Effects of probiotics on atopic dermatitis: a randomized controlled trial. Arch. Dis. Child. 2005, 90(9):892-897.
82. Wickens K., Black P.N., Stanley T.V. A differential effect of 2 probiotics in the prevention of eczema and atopy: a double-blind, randomized, placebo-controlled trial. J. Allergy Clin. Immunol. 2008, 122(4):788-794.
83. Yadav N.R., Bhitre M.A.I. Probiotic delivery systems: applications, challenges and prospectives. Int. Res. J. Pharm. 2013, 4(4).
84. Yadav H., Jain S., Sinha P.R. The effect of probiotic dahi containing Lactobacillus acidophilus and Lactobacillus casei on gastropathic consequences in diabetic rats. J. Med. Food 2008, 11:62-68.
85. Yasui H., Nagaoka N., Mike A. Detections of bifidobacterium strains that induce large quantities of IgA. Microb. Ecol. Health Dis. 1992, 5:155-162.
86. Yoo S.R., Kim Y.J., Park D.Y., Jung U.J., Jeon S.M., Ahn Y.T. Probiotics L. plantarum and L. curvatus in combination alter hepatic lipid metabolism and suppress diet-induced obesity. Obesity (Silver Spring) 2013, 21:2571-2578.
87. Yun S.I., Park H.O., Kang J.H. Effect of Lactobacillus gasseri BNR17 on blood glucose levels and body weight in a mouse model of type 2 diabetes. J. Appl. Microbiol. 2009, 107:1681-1686.
88. Zhao X., Higashikawa F., Noda M., Kawamura Y., Matoba Y., Kumagai T. The obesity and fatty liver are reduced by plant-derived Pediococcus pentosaceus LP28 in high fat diet-induced obese mice. PLoS One 2012, 7(2).
89. Coccorullo P., Strisciuglio C., Martinelli M., Miele E., Greco L., Staiano A. Lactobacillus reuteri (DSM 17938) in infants with functional chronic constipation: a double-blind, randomized, placebo-controlled study. J. Pediatr. 2010, 157:598-602.
90. Narbona Lopez E., Uberos Fernandez J., Armada Maresca M.I., Couce Pico M.L., Rodriguez Martinez G., Saenz de Pipaon M. Nutrition and Metabolism Group of the Spanish Neonatology Society: recommendations and evidence for dietary supplementation with probiotics in very low birth weight infants. An. Pediatr. 2014, 81(6):397.
91. Perdigon G., Alvarez S., Medina M., Vintini E., Roux E. Influence of the oral administration of lactic acid bacteria on iga producing cells associated to bronchus. Int. J. Immunopathol. Pharmacol. 1999, 12:97-102.
92. Wong V.W., Tse C.H., Lam T.T. Molecular characterization of the fecal microbiota in patients with nonalcoholic steatohepatitis-a longitudinal study. PLoS One 2013, 8(62885).